Cai 2012.
| Methods | RCT design: 2‐arm parallel‐group trial Total N randomised: 126 Length of follow‐up: 4 weeks of intervention with no follow‐up Analysis: unclear (method of analysis not explicitly stated; dropouts unclear) |
| Participants | Location: China Number of study centres and setting: unclear CAD criteria: unstable angina, not further specified Depression criteria: unclear. Clinical Global Impression used to quantify change. Other entry criteria: unclear Exclusion criteria: unclear Treatment N: 66 (no demographics reported) Control N: 60 (no demographics reported) Comparability of groups: no comparisons reported |
| Interventions | Treatment: flupentixol melitracen (trade name Deanxit), 1 or 2 pieces for 4 weeks Control: unclear Duration of treatment: 4 weeks |
| Outcomes | Cinical global improvement in depression and anxiety, incidence of angina pectoris and malignant cardiovascular events |
| Notes | Conference abstract only. Department of Cardiology, Affiliated Hospital of Gannan Medical College, JiangXi, GanZhou, China |